Paper40940959
Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.
Skribek B and 10 others. Cancers (Basel), 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. Papers, record 40940959. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40940959
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30768957 | Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome. | Magn Reson Imaging | 2019 | https://conductscience.org/library/papers/30768957 | PubMed |
| 2 | 26951947 | Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort. | Eur Urol | 2016 | https://conductscience.org/library/papers/26951947 | PubMed |
| 3 | 19638912 | The Clavien-Dindo classification of surgical complications: five-year experience. | Ann Surg | 2009 | https://conductscience.org/library/papers/19638912 | PubMed |
| 4 | 29107031 | Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound. | J Urol | 2018 | https://conductscience.org/library/papers/29107031 | PubMed |
| 5 | 36073928 | Focal Therapy of Prostate Cancer Index Lesion With Irreversible Electroporation. A Prospective Study With a Median Follow-up of 3 Years. | J Urol | 2023 | https://conductscience.org/library/papers/36073928 | PubMed |
| 6 | 21354037 | [Outcomes of HIFU for localised prostate cancer using the Ablatherm Integrate Imaging® device]. | Prog Urol | 2011 | https://conductscience.org/library/papers/21354037 | PubMed |
| 7 | 16857310 | Control of prostate cancer by transrectal HIFU in 227 patients. | Eur Urol | 2007 | https://conductscience.org/library/papers/16857310 | PubMed |
| 8 | 17572198 | Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. | Urology | 2007 | https://conductscience.org/library/papers/17572198 | PubMed |
| 9 | 33926838 | Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance. | Eur Urol Focus | 2022 | https://conductscience.org/library/papers/33926838 | PubMed |
| 10 | 22928703 | Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. | BJU Int | 2012 | https://conductscience.org/library/papers/22928703 | PubMed |
| 11 | 32701978 | Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre. | PLoS One | 2020 | https://conductscience.org/library/papers/32701978 | PubMed |
| 12 | 33529137 | MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. | Radiology | 2021 | https://conductscience.org/library/papers/33529137 | PubMed |
| 13 | 33492425 | Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer. | World J Urol | 2022 | https://conductscience.org/library/papers/33492425 | PubMed |
| 14 | 39468217 | Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?-a systematic review and meta-analysis. | Prostate Cancer Prostatic Dis | 2025 | https://conductscience.org/library/papers/39468217 | PubMed |
| 15 | 29223469 | Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis. | Eur J Surg Oncol | 2018 | https://conductscience.org/library/papers/29223469 | PubMed |
| 16 | 23092060 | Interrater reliability: the kappa statistic. | Biochem Med (Zagreb) | 2012 | https://conductscience.org/library/papers/23092060 | PubMed |
| 17 | 36910902 | Irreversible electroporation for prostate cancer using PSMA PET-CT. | Prostate Int | 2023 | https://conductscience.org/library/papers/36910902 | PubMed |
| 18 | 33983695 | Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature. | Oncology (Williston Park) | 2021 | https://conductscience.org/library/papers/33983695 | PubMed |
| 19 | 31161973 | Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes. | Radiology | 2019 | https://conductscience.org/library/papers/31161973 | PubMed |
| 20 | 32562361 | Optimally estimating the sample standard deviation from the five-number summary. | Res Synth Methods | 2020 | https://conductscience.org/library/papers/32562361 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NPEPPS | 9520 | PubTator's text mining | https://conductscience.org/library/genes/9520 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40940959
GET https://conductscience.org/api/papers/v1/40940959/references?page=2